Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Simvastatin for Recurrent Prostate Cancer
NCT01561482Phase 2Withdrawn
- Start
- Jan 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin and simvastatin in prostate carcinoma. Primary endpoint: PSA Doubling Time at 6 months. Planned start Jan 2012; status: withdrawn.
02
Drugs
metforminsimvastatin
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT01561482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561482.